Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

Abstract In prostate cancer (PCa), the use of new radiopharmaceuticals has improved the accuracy of diagnosis and staging, refined surveillance strategies, and introduced specific and personalized radioreceptor therapies. Nuclear medicine, therefore, holds great promise for improving the quality of...

Full description

Bibliographic Details
Main Authors: Virginia Liberini, Riccardo Laudicella, Michele Balma, Daniele G. Nicolotti, Ambra Buschiazzo, Serena Grimaldi, Leda Lorenzon, Andrea Bianchi, Simona Peano, Tommaso Vincenzo Bartolotta, Mohsen Farsad, Sergio Baldari, Irene A. Burger, Martin W. Huellner, Alberto Papaleo, Désirée Deandreis
Format: Article
Language:English
Published: SpringerOpen 2022-06-01
Series:European Radiology Experimental
Subjects:
Prostate cancer
Positron emission tomography
Artificial intelligence
Radiomics
Theragnostics
Online Access:https://doi.org/10.1186/s41747-022-00282-0

Internet

https://doi.org/10.1186/s41747-022-00282-0

Similar Items